Definitive Contract HT942525CE041
- Not listed
- <p>The Department of Defense, Army Medical Command awarded a $1,099,933 firm fixed price contract to Chromologic LLC for medical research and development of a Ceramic Membrane Based Portable Oxygen Generator under the Small Business Innovation Research Program Phase II solicitation number 21.1. Chromologic will perform the research and development work in Monrovia, California from September 2022 through January 2025. The contract has a total small business set aside designation.</p>
- The Department of the Army Medical Command awarded a Firm Fixed Price Purchase Order for $249,977.01 to Chromologic LLC, a minority-owned, small business limited liability company, to conduct research and development under the SBIR Phase I program for a project titled "Ceramic Membrane Based Portable Oxygen Generator (CEMPOG)". The contract has a Total Small Business set aside designation. Chromologic is an experienced federal contractor that has provided research, development, and...
- This award is for a $1,074,903.98 Firm Fixed Price contract under the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) program. The contract was awarded to Chromologic LLC, a minority-owned small business, for the development of a Phase II project titled "In-Line, Non-Invasive, Non-Destructive Cell Monitoring in Dynamically Growing Cultures". The project was solicited under DHA SBIR Topic DHA18-006, and the work is to be performed in Monrovia, California....
- The Defense Health Agency has awarded a Phase II Small Business Innovation Research (SBIR) contract to TDA Research, Inc., a small business specializing in advanced research and engineering solutions for federal agencies. Valued at $1.3 million with a completion date of September 25, 2027, this definitive firm fixed-price contract supports the development of a stackable portable oxygen generator designed for deployed Army casualty care. The work will be performed in Golden, Colorado, and is...
- This contract was awarded by the Defense Health Agency (DHA) to Chromologic LLC, a minority-owned small business, to conduct SBIR Phase I research and development on an "Antiseptic, Warming, and Alternating Pressure Pad (AWAPAD)". The $162,482.50 firm fixed price contract has a completion date of February 7, 2020. Chromologic is a provider of medical device, pharmaceutical, and countermeasure R&D services, with prior SBIR/STTR awards from agencies like the Departments of Defense...
- This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Chromologic LLC, a small business contractor, under the Small Business Innovation Research (SBIR) Program. The contract, with a Firm Fixed Price of $999,912.00, is for the development of a "Self-Healing Elastomer for Medical Simulation & Training" as part of DHA's Medical R&D efforts. Chromologic, a Minority Owned, American Indian Owned, and Subcontinent Asian American Owned Limited Liability Company,...
- The Office of Naval Research awarded a Small Business Innovation Research (SBIR) Phase II contract to Chromologic LLC, a minority-owned small business based in Monrovia, California, with a ceiling value of $1.99 million and a completion date of September 30, 2027. This Cost Plus Fixed Fee definitive contract was awarded on January 3, 2024, as a total small business set-aside, reflecting the government's commitment to supporting small business innovation in defense-related research and...
- This contract award to Chromologic LLC, a minority-owned limited liability company, is for a $1,099,988.76 Small Business Innovation Research (SBIR) Phase II contract with the Defense Microelectronics Activity (DMEA), a component of the U.S. Department of Defense. The contract, designated as a total small business set-aside, supports Chromologic's research and development efforts for advanced microelectronics technologies. As a leading provider of innovative products and services to various...
- The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $2,998,822.37 firm fixed price Small Business Innovation Research (SBIR) Phase II contract to Boundless Science, LLC, a small business, to develop an Acute Respiratory Distress Syndrome (ARDS) Oxygenation Device (AOD). The contract, which is set aside for small businesses, will fund research and development efforts by Boundless Science in Chapel Hill, North Carolina through October 2026. Boundless Science has received...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Chromologic LLC, a minority-owned small business, to design, develop, and construct a breadboard prototype for an on-demand process to generate 10-15% concentrations of aqueous hydrogen peroxide. The $167,466.50 contract has a firm fixed price and a completion date of October 27, 2021. Chromologic, a manufacturer of goods, has...
The Defense Health Agency (DHA) awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Chromologic LLC, a minority-owned small business based in Monrovia, California, to develop a ceramic membrane-based portable oxygen generator for medical-grade oxygen supply to forward surgical teams. This sequential Phase II award, with a completion date of January 29, 2028, represents a continuation of research initiated in an earlier Phase I project and reflects the DHA's investment in innovative technologies that enhance medical support capabilities in field operations. The contract is designated as a total small business set-aside, underscoring the government's commitment to fostering small business participation in critical defense health initiatives. Chromologic brings substantial expertise to this effort, having established a track record in advanced medical device development and SBIR/STTR programs across multiple federal agencies including the Department of Defense, DARPA, and the National Institutes of Health. The company's prior work on membrane-based devices and portable oxygen generation systems, combined with its experience in biomedical engineering and medical device innovation, positions it well to deliver a deployable solution that addresses the operational requirements of combat support hospitals and forward surgical teams. Under the firm fixed-price contract structure, Chromologic will develop and advance this oxygen generation technology to support enhanced medical readiness in field environments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $649.9k | 9/22/25 |